WASHINGTON (dpa-AFX) - Rigel Pharmaceuticals, Inc. (RIGL) said Tuesday that it plans to offer and sell shares of its common stock in an underwritten public offering.
The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
All of the shares to be sold in the offering are to be sold by Rigel, with the proceeds to be used to fund research and development activities and for general corporate purposes.
Jefferies & Company, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the proposed offering, with Citigroup acting as lead manager, and BMO Capital Markets, Piper Jaffray & Co. and Wells Fargo Securities, LLC acting as co-managers.
Copyright RTT News/dpa-AFX
Kostenloser Wertpapierhandel auf Smartbroker.de